Pulmonary complications include a wide spectrum of microorganisms—bacteria, viruses, and protozoa. HBOT used as adjunct therapy in the prophylaxis and treatment in pulmonary diseases. P.carinii is a protozoa is an anaerobe that responds well to HBOT treatment. HBOT with Bactrim increases tissue permeability.
Intervention with HBOT in addition to antibiotic and antiprotozoal therapy improves patient outcome by reducing hypoxia enhanced antimicrobial effects of pharmaceuticals and suppressing P. carinii. Mycobacterium tuberculosis (MTB) is increasingly occurring in HIV-infected patients. MTB affects about one in five individuals who have HIV in major cities. Many of the medications produce side effects including liver dysfunction, nausea, diarrhea and wasting; HBOT helps to deal with the side effects.